Nancy Pei is a principal in Smart & Biggar's Toronto office. With hands-on experience as a licensed pharmacist and over 25 years of patent litigation expertise, Nancy has established a successful IP practice focused exclusively in the field of life sciences, with an emphasis on pharmaceuticals and biologics. Nancy’s clients benefit not only from the depth and breadth of her experience but also from her unique insights on broader patenting, regulatory and business issues, helping them manage the life cycles of their products and remain competitive in an ever-changing industry. As a patent litigator, Nancy represents innovative life sciences companies in patent litigation, including actions under the Patented Medicines (Notice of Compliance) Regulations. She has represented clients before the Federal Court of Canada, the Federal Court of Appeal, the Supreme Court of Canada, and the Ontario Superior Court of Justice. She also represents clients in judicial review applications. Nancy has been the editor of Rx IP Update, the firm's monthly life sciences intellectual property and regulatory newsletter, since its inception in 2001 and co-editor as of 2023. Nancy currently serves on the board of directors of BIOTECanada.
